Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Prabhakar, Raj"'
2
Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)
Autor: Darren Cowzer, Ronak H. Shah, Sippy Punn, Laura Fiedler, April DeMore, Joanne F. Chou, Marinela Capanu, Michael F. Berger, Diane Reidy-Lagunes, Nitya Prabhakar Raj
Publikováno v: Journal of Clinical Oncology. 41:653-653
653 Background: PanNENs represent 1-2% of all pancreatic neoplasms. The genomic landscape derived from PanNEN tumor tissue has been described previously. There are little data detailing the frequency of genetic alterations identified in cfDNA in an a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::49146f3fc342828f0d66d5a7bb37292c
https://doi.org/10.1200/jco.2023.41.4_suppl.653
Zobrazit plný text záznamu
5
Treatment response and clinical outcomes of neuroendocrine neoplasms treated with immune checkpoint inhibitors: A single-institution experience
Autor: Haley Hauser, Tiffany Le, Joanne F. Chou, Olivia Heffernan, April DeMore, Selin Gonen, Marinela Capanu, Diane Lauren Reidy, Nitya Prabhakar Raj
Publikováno v: Journal of Clinical Oncology. 40:506-506
506 Background: Immune checkpoint inhibitors (ICIs) have antitumor activity in some solid tumors, however a role for ICI’s in the treatment of neuroendocrine neoplasms (NENs) is uncertain. We analyzed response and outcomes of NENs, both well differ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7d5e5534ac9aa031acd53fde8d323b51
https://doi.org/10.1200/jco.2022.40.4_suppl.506
Zobrazit plný text záznamu
6
Early-onset well differentiated pancreatic neuroendocrine tumors: Clinical presentation, pathologic features, and oncological outcomes
Autor: Alessandra Pulvirenti, Haley Hauser, Tiffany Le, Caitlin A. McIntyre, Diane Lauren Reidy, Alice Chia-chi Wei, Nitya Prabhakar Raj
Publikováno v: Journal of Clinical Oncology. 40:507-507
507 Background: Young onset of several gastrointestinal cancers is associated with more advanced disease and poor oncological outcomes, however, this association has not been fully investigated for well differentiated pancreatic neuroendocrine tumors
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1490d2dda6ed6c45b7d5da087f70b562
https://doi.org/10.1200/jco.2022.40.4_suppl.507
Zobrazit plný text záznamu
7
Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104
Autor: Heloisa P. Soares, Katherine A Guthrie, Syed A. Ahmad, Mary Kay Washington, Brian Hemendra Ramnaraign, Nitya Prabhakar Raj, Carole Seigel, Shay Bellasea, E. Gabriela Chiorean, Arvind Dasari, Jonathan R. Strosberg, Cathy Eng, Philip Agop Philip
Publikováno v: Journal of Clinical Oncology. 40:TPS515-TPS515
TPS515 Background: Pancreatic neuroendocrine tumors (pNETS) account for about 1-2% of all the pancreas tumors for which resection is the only curative intent modality, however, despite surgery, many patients will experience recurrence. Tumor size, po
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8624a9a2a163af0799bdcfa415d0cc7
https://doi.org/10.1200/jco.2022.40.4_suppl.tps515
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje